Suaib, Marwa M.

HRN: 23-39-14  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2023
AMPICILLIN 1GM (VIAL)
09/04/2023
09/06/2023
IV
2gms
Q6H
PROM
Waiting Final Action 
09/05/2023
CO-AMOXICLAV 625MG (TAB)
09/05/2023
09/11/2023
ORAL
625mg
BID
PROM
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: